Compound traditional Chinese medicine formulation with dandelion herb for use in cancer chemoradiotherapy stage

The invention belongs to the field of traditional Chinese medicine formulations and provides a compound traditional Chinese medicine formulation with dandelion herb for use in cancer chemoradiotherapystage, comprising effective ingredients and pharmaceutically acceptable auxiliaries; the effective ingredients include, by weight, 15-35 g of dandelion herb, 9-18 g of immature flower of wild honeysuckle, 9-18 g of Hangzhou chrysanthemum flower, 9-23 g of common lophatherum herb, 2-5 g of saffron, 6-11 g of root of dahurian angelica, 5-9 g of fruit of large-fruited Chinese hawthorn, 7-12 g of tangerine peel, 5-9 g of rhizome of common ginger, 7-12 g of seed of bitter apricot, 9-14 g of fruit of medicinal citron, and 3-7 g of root of ural licorice. Aiming at the physical and mental conditionsof a patient with cancer during chemoradiotherapy, the compound traditional Chinese medicine formulation with dandelion herb for use in cancer chemoradiotherapy stage enables the problems to be solvedthat a patient with cancer